Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros







Base de dados
Indicadores
Intervalo de ano de publicação
1.
Hematol., Transfus. Cell Ther. (Impr.) ; 44(4): 497-503, Oct.-dec. 2022. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1421520

RESUMO

ABSTRACT Introduction: People living with human immunodeficiency virus (PLWH) still face high morbidity and mortality resulting from lymphoma. Aim: To describe a population of PLWH and lymphoma in a Chilean public hospital and compare the overall survival (OS) with a previously reported cohort from the same institution. Methods: Retrospective single-center cohort study. All the patients diagnosed between 2010 and 2017 were included. Demographic and clinical variables were obtained from medical records. The overall survival (OS) was estimated in treated patients from diagnosis until death or October 2020. The OS was then compared with a cohort of patients diagnosed between 1992 and 2008. Main Results: Eighty-four patients were included. The most common histological types were Burkitt's lymphoma (BL), diffuse large B-cell lymphoma (DLBCL), Hodgkin's lymphoma (HL) and plasmablastic lymphoma (PBL) at 31%, 27%, 21% and 14%, respectively. The three-year OS for the whole cohort of BL, DLBCL, HL and PBL was 58.9%, 65.2%, 47.4%, 76.4% and 50%, respectively. Compared to the cohort of 1992 to 2008, a global increase in the OS was found after excluding HL and adjusting for age and clinical stage (HR 0.38, p = 0.002). However, when the main types were analyzed individually, the increase in the OS was statistically significant only in DLBCL (HR 0.29, p = 0.007). Most patients with DLBCL received CHOP chemotherapy, as in the previous cohort. Conclusion: The OS has improved in this population, despite no major changes in chemotherapy regimens, mainly due to the universal access to antiretroviral therapy.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Adulto Jovem , Linfoma Difuso de Grandes Células B , Linfoma de Burkitt , Síndrome da Imunodeficiência Adquirida , Linfoma Plasmablástico , Prognóstico , Sobrevida , Doença de Hodgkin , Estudos de Coortes
2.
Rev. méd. Chile ; 147(7): 842-851, jul. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1058613

RESUMO

Background: Except for influenza pandemics, different observational studies have failed to demonstrate differences in mortality between various etiologies in adult patients hospitalized for respiratory infections. Aim: To compare clinical and mortality differences between different viral pathogens associated with severe acute respiratory infections (SARI) in hospitalized adults. Material and Methods: One-year prospective study in a sentinel center. We included 132 patients with SARI hospitalized for any of the nine viruses under study by PCR. Clinical variables were compared, excluding cases of coinfection. Results: A viral coinfection was identified in 12% and influenza infection in 56% of cases. Eighty percent of patients were aged ≥ 65 years, with a high frequency of comorbidities, 27% were bedridden. Twenty four percent were admitted to critical care units, 20% required ventilatory assistance and 16% died. Cases occurred throughout the year, with an expected seasonal peak between autumn and spring and a predominance of infections not associated with influenza during summer months. In the multivariate analysis, only being bedridden was significantly associated with mortality at discharge (Odds ratio 23.46; 95% confidence intervals 3.33-165.12, p < 0.01), without association with age, comorbidity, viral pathogen involved, laboratory parameters, clinical presentation or CURB65 score. No major clinical dissimilarities were found between different viral pathogens. Conclusions: In our series of patients, mostly elderly, only bedridden status was significantly associated with mortality at discharge in patients hospitalized for SARI. Viral pathogens were not relevant.


Los factores del huésped son más importantes que el tipo viral para predecir el desenlace en pacientes hospitalizados por infecciones respiratoria aguda grave. Exceptuando las pandemias de influenza, diferentes estudios observacionales no han logrado demostrar diferencias en mortalidad entre diferentes patógenos en pacientes adultos hospitalizados por infecciones respiratorias. Objetivo: Comparar diferencias clínicas y en mortalidad entre diferentes patógenos virales asociados a infección respiratoria aguda grave (IRAG) en adultos hospitalizados. Método: Estudio prospectivo durante un año en un centro centinela. Se incluyeron casos de IRAG hospitalizados por alguno de los 9 virus bajo estudio por RCP. Se compararon variables clínicas y desenlace. Resultados: Ingresaron 132 pacientes con IRAG. Se identificó coinfección viral en 12,1% e infección por influenza en 56,1%. La mayor parte era de la tercera edad (80,3%) con una alta frecuencia de comorbilidad y 27,3% estaba postrado. Veintitres coma cinco por ciento ingresó a unidad de cuidados críticos, 19,7% requirió asistencia ventilatoria y 15,9% fallecieron. Los casos ocurrieron todo el año, con un aumento estacional esperado entre otoño y primavera y predominio de infecciones no asociadas a influenza en verano. En el análisis multivariado, sólo la postración se asoció significativamente a mortalidad al egreso (ORa 23,46 IC95 3,33-165,12, p = 0,002), sin asociación con la edad, comorbilidad, patógeno viral involucrado, parámetros de laboratorio, presentación clínica o puntuación CURB65. No se encontraron discordancias clínicas mayores entre diferentes agentes virales. Conclusiones: En nuestra serie de pacientes, mayoritariamente de la tercera edad, sólo la postración se asoció significativamente a mortalidad al egreso en pacientes hospitalizados por IRAG. El patógeno viral no resultó ser relevante.


Assuntos
Humanos , Masculino , Feminino , Adulto , Idoso , Infecções Respiratórias/mortalidade , Infecções Respiratórias/virologia , Estações do Ano , Índice de Gravidade de Doença , Doença Aguda , Estudos Prospectivos , Fatores de Risco , Hospitalização
3.
Rev. panam. salud pública ; 43: e1, 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-985764

RESUMO

ABSTRACT Objective To 1) describe clinical characteristics of adult patients in Chile with severe acute respiratory infections (SARI) associated with influenza viruses, and 2) analyze virus subtypes identified in specimens collected from those patients, hospital resources used in clinical management, clinical evolution, and risk factors associated with a fatal outcome, using observational data from the SARI surveillance network (SARInet). Methods Adults hospitalized from 1 July 2011 to 31 December 2015 with influenza-associated SARI at a SARI sentinel surveillance hospital in Santiago were identified and the presence of influenza in all cases confirmed by reverse transcription polymerase chain reaction (RT-PCR), using respiratory samples. Results A total of 221 patients (mean age: 74.1 years) were hospitalized with influenza-associated SARI during the study period. Of this study cohort, 91.4% had risk factors for complications and 34.3% had been vaccinated during the most recent campaign. Pneumonia was the most frequent clinical manifestation, occurring in 57.0% of the cohort; other manifestations included influenza-like illness, exacerbated chronic bronchitis, decompensated heart failure, and asthmatic crisis. Cases occurred year-round, with an epidemic peak during autumn-winter. Both influenza A (H1N1pdm09 and H3N2) and B virus co-circulated. Critical care beds were required for 26.7% of the cohort, and 19.5% needed ventilatory assistance. Multivariate analysis identified four significant factors associated with in-hospital mortality: 1) being bedridden (adjusted odds ratio (aOR): 22.3; 95% confidence interval (CI): 3.0-164); 2) admission to critical care unit (aOR: 8.9; CI: 1.44-55); 3) Pa02/Fi02 ratio < 250 (aOR: 5.8; CI: 1.02-33); and 4) increased serum creatinine concentration (> 1 mg/dL) (aOR: 5.47; CI: 1.20-24). Seasonal influenza vaccine was identified as a significant protective factor (aOR: 0.14; CI: 0.021-0.90). Conclusions Influenza-associated SARI affected mainly elderly patients with underlying conditions. Most patients evolved to respiratory failure and more than one-quarter required critical care beds. Clinical presentation was variable. Death was associated with host characteristics and disease-associated conditions, and vaccine was protective. Virus type did not influence outcome.


resumen está disponible en el texto completo


RESUMO Objetivo Descrever as características clínicas de pacientes adultos com infecção respiratória aguda grave (SARI) associada ao vírus da influenza e analisar os subtipos virais identificados em amostras coletadas destes pacientes, os recursos hospitalares empregados no tratamento clínico, a evolução clínica e os fatores de risco clínicos associados a um desfecho fatal, a partir de dados observacionais da rede de vigilância de SARI (SARInet) no Chile. Métodos Foram identificados os adultos hospitalizados com SARI associada a influenza em um hospital-sentinela de vigilância de SARI, em Santiago, de 1o de julho de 2011 a 31 de dezembro de 2015. A ocorrência de influenza foi confirmada em amostras respiratórias em todos os casos com a reação em cadeia da polimerase via transcriptase reversa (RT-RCP). Resultados Ao todo, 221 pacientes (idade média de 74,1 anos) foram hospitalizados com SARI associada a influenza no período de estudo. Nesta coorte, 91,4% apresentavam fatores de risco para complicação e 34,3% haviam sido vacinados na última campanha de vacinação. Pneumonia foi a manifestação clínica mais frequente, ocorrendo em 57,0% da coorte. Outras manifestações foram doença gripal, bronquite crônica exacerbada, insuficiência cardíaca descompensada e crise asmática. Os casos estiveram distribuídos ao longo do ano, com pico epidêmico no outono-inverno. Houve circulação simultânea dos vírus da influenza A (H1N1pdm09 e H3N2) e B. Leitos de terapia intensiva foram necessários em 26,7% da coorte e suporte ventilatório, em 19,5%. Na análise multivariada, quatro fatores importantes associados à mortalidade hospitalar foram identificados: estar restrito ao leito (odds ratio ajustado [ORaj] 22.3; intervalo de confiança de 95% [IC 95%] 3.0-164); ser admitido na unidade de terapia intensiva (ORaj 8.9, IC 95% 1.4 4-55); relação Pa02/Fi02 <250 (ORaj 5.8; IC 95% 1.02-33) e aumento da creatinina sérica (>1 mg/dl) (ORaj 5.47; IC 95% 1.20-24). A vacinação sazonal contra influenza foi identificada como importante fator de proteção (ORaj 0.14; IC 95% 0.021-0.90). Conclusões A SARI associada a influenza acometeu sobretudo pacientes idosos com doenças preexistentes. A maioria dos pacientes evoluiu com insuficiência respiratória e mais de um quarto precisou de cuidados intensivos. O quadro clínico foi variável. Morte foi associada às características do hospedeiro e problemas relacionados à doença. A vacinação teve efeito protetor e o tipo viral não influiu no desfecho.


Assuntos
Infecções Respiratórias/complicações , Evolução Fatal , Influenza Humana/transmissão , Chile
4.
Rev. chil. infectol ; 33(3): 322-330, jun. 2016. ilus
Artigo em Espanhol | LILACS | ID: lil-791027

RESUMO

Introducción: La espondilodiscitis (ED) implica prolongados períodos de hospitalización, de latencia diagnóstica y riesgo de complicaciones a largo plazo. No existen publicaciones recientes en Chile al respecto. Objetivos: Caracterizar un grupo de pacientes con ED. Pacientes y Métodos: Serie clínica, que incluyó pacientes en un período de ocho años. Resultados: 37 pacientes, 37,8% mujeres y 62,2% hombres, con promedio etario 66,8 años; 64,9% adultos mayores, 35,1% diabéticos y 21,6% con co-morbilidad urológica. Los principales síntomas fueron dolor y fiebre. 89,2% tuvo elevación de VHS. 86,5% contó con resonancia magnética, que siempre fue confirmatoria, siendo la columna lumbar la localización más frecuente (43,2%). Se identificó etiología en 28/37 pacientes: en 71,4% cocáceas grampositivas (Staphylococcus aureus predominantemente), sólo en 10,7% M. tuberculosis. Staphylococcus aureus estuvo asociado a co-morbilidades médicas en forma significativa (p < 0,05) y el grupo de bacilos gramnegativos a historia hepatobiliar y/o intestinal (p < 0,05). El método de mayor rendimiento fue el cultivo obtenido por punción quirúrgica. El tratamiento antimicrobiano fue indicado en promedio por 63,8 días (IQR 53-72), con reacciones adversas en 18,9%. La estadía hospitalaria fue 38,9 días promedio, no existiendo fallecidos durante este período. 18,9% presentó secuelas motoras. Discusión: La mayoría de pacientes con ED correspondió a adultos mayores, siendo S. aureus la principal etiología. Hubo una baja frecuencia de M. tuberculosis. Resultó considerable la magnitud de efectos adversos asociados a la terapia antimicrobiana y las complicaciones neurológicas.


Background: Spondylodiscitis (SD) involves long periods of hospitalization, diagnostic latency and risk of long-term complications. No updated series are available in Chile and a change in demographic features and etiology is suspected. Aim: To characterize a group of patients with SD. Patients and Methods: Clinical series including patients over an 8 year period. Results: We identified 37 patients; 37.8% women and 62.2% men (mean age 66.8 years); 64.9% were elderly; 35.1% had diabetes and 21.6% urological comorbidity. Main symptoms were pain and fever. Erythrocyte sedimentation rate was elevated in 89.2%, and 86.5% patients had MRI, which was always confirmatory. Lumbar spine was the most common site of infection (43.2%). Etiology was identified in 28/37 patients: 71.4% yielded grampositive cocci (Staphylococcus aureus predominantly), Mycobacterium tuberculosis was identified in only 10.7%. Staphylococcus aureus was associated to medical comorbidities (p < 0,05) and gramnegative bacilli to hepatobiliar or intestinal symptoms (p < 0,05). Culture obtained by a surgical procedure had the highest yield. The average duration of antibiotic therapy was 63.8 days (IQR 53-72). Treatment-related side effects were detected in 18.9% of patients. The average hospital stay was 38.9 days. No deaths occurred during hospitalization. Motor sequelae were present in 18.9% of this series. Discussion: Most patients with SD were older adults. Staphylococcus aureus was predominant and M. tuberculosis was uncommon. Antibiotic side effects were relevant as well as the neurological complications.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Discite/microbiologia , Discite/epidemiologia , Osteomielite/microbiologia , Osteomielite/epidemiologia , Doenças da Coluna Vertebral/microbiologia , Doenças da Coluna Vertebral/epidemiologia , Infecções Estafilocócicas/microbiologia , Infecções Estafilocócicas/epidemiologia , Staphylococcus aureus/isolamento & purificação , Discite/terapia , Comorbidade , Chile/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Resultado do Tratamento , Distribuição por Sexo , Bactérias Aeróbias Gram-Negativas/isolamento & purificação , Bactérias Gram-Positivas/isolamento & purificação , Hospitais Gerais/estatística & dados numéricos
5.
Rev. chil. infectol ; 32(6): 609-617, graf, tab
Artigo em Espanhol | LILACS | ID: lil-773266

RESUMO

Background: Cotrimoxazole is a therapeutic option for bone-related infections but is associated to hyperkalemia and renal failure. Tolerance to this drug may reduce length of stay (LOS) and hospital charges. Aims: To evaluate renal, potassium toxicity, clinical outcome, and use of hospital resources in patients treated with cotrimoxazole for bone-related infections. Methods: Retrospective analysis of adult patients with bone-related infections confirmed by culture and treated with this drug. Serum potassium and creatinine levels were analyzed during follow-up and risk factors for hyperkalemia were searched. Length of stay (LOS) and hospital charges were compared. Clinical outcome was evaluated as a secondary endpoint. Results: From 2011 to 2014, 23 patients were identified (mean age 64.7 years). Diabetes mellitus, peripheral vascular disease, and previous amputations prevalence were high (82.6%, 47.8%, and 43.5%, respectively). Median serum potassium concentration increased significantly at first control (4.35 mEq/L to 4.9 mEq/L; p < 0.001), and also creatinine serum concentration (0.9 to 1.1 mg/dL; p < 0.05). Seven patients developed hyperkalemia. Cotrimoxazole was discontinued in 10 patients (43.5%), and in 6, discharge was postponed. Drugs active against the renin-angiotensin system (DAARAS) were associated with kyperkalemia (OR 10.8 IC95 1.37-85; p < 0.05). LOS was higher among patients with cotrimoxazole toxicity (median LOS 56 versus 30 days, p < 0.05). Patients with no cotrimoxazole interruption had less drug-related hospital charges (median values of 563 versus 2820 USD, respectively; p < 0.01). Conclusions: Cotrimoxazole use must be monitored in order to detect hyperkalemia or renal toxicity and suspend its prescription. Patients that use DAARAS have a higher risk of kyperkalemia. LOS and drug-related hospital charges are reduced when patients can tolerate cotrimoxazole.


Antecedentes: Cotrimoxazol es una alternativa en infecciones óseas pero se ha asociado al desarrollo de falla renal e hiperkalemia. Objetivo: Evaluar toxicidad renal, hiperkalemia, estadía y gastos hospitalarios y evolución clínica en un grupo de pacientes con infecciones óseas tratados con este compuesto. Pacientes y Métodos: Estudio retrospectivo-descriptivo de pacientes adultos con infecciones óseas confirmadas con cultivos y tratados con este compuesto. Seguimiento de creatinina y kalemia y búsqueda de factores de riesgo para hiperkalemia, comparación de gastos y estadía hospitalaria y análisis de eficacia clínica. Resultados: Desde el año 2011 al 2014 se identificaron 23 pacientes (promedio de edad 64,7 años). La prevalencia de diabetes mellitus tipo 2 (82,6%), enfermedad vascular periférica (47,8%) y amputaciones previas (43,5%) fue elevada. La mediana de la kalemia basal aumentó significativamente al primer control (4,35 a 4,9 mEq/L) al igual que la creatinina plasmática (0,9 a 1,1 mg/dL). Siete pacientes desarrollaron hiperkalemia (30,4%). Se suspendió cotrimoxazol en 10 casos (43,5%) y en 6 casos se postergó el alta. El uso de fármacos activos contra el sistema renina-angiotensina (FASRA) se asoció a hiperkalemia (OR 10,8 IC95 1,37-85; p < 0,05). La estadía hospitalaria fue mayor en el grupo con toxicidad a cotrimoxazol (mediana de 56 versus 30 días; p < 0,05) y los pacientes sin suspensión de terapia tuvieron menos gastos por fármacos (medianas de 563 vs 2.820 USD, p < 0,01). Conclusiones: El uso de cotrimoxazol debe ser monitorizado para detectar hiperkalemia o toxicidad renal y suspender su prescripción. Los pacientes que usan FASRA tienen mayor riesgo de hiperkalemia. La estadía y gastos hospitalarios por fármacos son menores en pacientes que toleran el cotrimoxazol.


Assuntos
Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Antibacterianos/efeitos adversos , Doenças Ósseas Infecciosas/tratamento farmacológico , Hiperpotassemia/induzido quimicamente , Combinação Trimetoprima e Sulfametoxazol/efeitos adversos , Antibacterianos/economia , Antibacterianos/uso terapêutico , Creatinina/sangue , Custos de Cuidados de Saúde , Tempo de Internação , Potássio/sangue , Estudos Retrospectivos , Fatores de Risco , Combinação Trimetoprima e Sulfametoxazol/economia , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico
6.
Infectio ; 19(1): 35-39, ene.-mar. 2015. ilus, tab
Artigo em Espanhol | LILACS, COLNAL | ID: lil-742601

RESUMO

La aspergilosis invasiva (AI) es causada por la inhalación de conidias del moho Aspergillus spp. , el cual tiene como hábitat el suelo. Ha sido descrita en pacientes con trasplante de médula ósea y neutropenia grave (<500 neutrófilos/mm 3 ). Los pacientes que ingresan a la unidad de cuidado intensivo (UCI) también pueden ser susceptibles a la AI, con otros factores de riesgo tales como: enfermedad pulmonar obstructiva crónica (EPOC), cirrosis hepática, enfermedades autoinmunes en manejo inmunosupresor y trasplante de órgano sólido, en donde la mortalidad puede llegar al 80%. Se describe el caso de un hombre de 56 años con antecedente de tabaquismo, sin confirmación espirométrica de EPOC, que presentó AI pulmonar durante su estancia en UCI. El diagnóstico fue confirmado por histopatología de úlcera en carina, cultivo de aspirado traqueal y galactomanan en lavado broncoalveolar. Voriconazol fue su tratamiento, con buena respuesta clínica.


Invasive aspergilosis (IA) is caused by Aspergillum particles inhalation such as mildew and yeast. They live in the soil as a natural habitat. This infection has been described in patients with a bone marrow transplant and serious neutropenia (<500mm 3 ). Inward patients of intensive care unit (ICU) can be also susceptible to them, and even more with risk factors associated such as chronic obstructive pulmonary disease (COPD), liver cirrhosis, autoimmune diseases with inmunosupressor therapy and solid organ transplantation, where mortality can reach 80% of cases. A case of IA in a man of 56 years old is described. He had smoking history without previous spirometric assessment. The patient developed IA during stay at the intensive care unit. Aspergillus septate hiphae were observed in the biopsy at the carina's ulcer. Galactomannan assay was positive in bronchioalvelar fluid. The patient had good clinical response to treatment with Voriconazole.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Aspergilose , Aspergillus , Cuidados Críticos , Unidades de Terapia Intensiva , Doenças Autoimunes , Úlcera , Fatores de Risco , Transplante de Órgãos , Doença Pulmonar Obstrutiva Crônica , Imunossupressores , Infecções , Cirrose Hepática
7.
Rev. chil. infectol ; 30(4): 417-425, ago. 2013. graf, tab
Artigo em Espanhol | LILACS | ID: lil-690530

RESUMO

Background: Listeria monocytogenes infections have been poorly characterized in Chile. ^4im: To evaluate clinical manifestations and risk factors associated to a fatal outcome in a series of patients. Methods: retrospective analysis of cases from 1991 to 2012. Results: Twenty three cases were identified, including 2 diagnosed after prolonged hospitalization (8.7%) with an average age of 68.4 years (range 44-90). Known predisposing factors were age > 65 years (60.9%), diabetes mellitus (40.9%), and immunosuppression (27.3%). Most cases presented after 2003 (70%). No cases associated with neonates, pregnancy or HIV infections were recorded. Patients presented with central nervous system (CNS) infection (39%), including 8 cases of meningitis and one of rhomboencephalitis; bacteremia (43.5%), including one case with endocarditis; abscesses (8.7%); and other infections (spontaneous bacterial peritonitis and pneumonia; 8.7%). Risky food consumption was found in 80% of those asked about it. Predominant clinical manifestations were fever (90.9%), and confusion (63.6%). CNS infections were associated to headache (OR 21, p < 0.05), nausea and vomiting (OR 50, p < 0.01). Only 45.5% received initial appropriate empirical therapy and 36.4% a synergistic combination. Eight patients died (34.8%), this outcome was associated to bacteremia (OR 8.25; IC95 1.2-59 p < 0.05). Conclusions: L. monocytogenes infections appear to be increasing in Chile, causing infections in different sites, attacking vulnerable patients, and have a high case-fatality ratio, especially among those with bacteremia.


Introducción: Las infecciones por Listeria monocytogenes representan una zoonosis con escasa caracterización clínica en Chile. Objetivo: Analizar manifestaciones clínicas y factores de riesgo asociados a desenlace fatal. Pacientes yMétodos: Estudio retrospectivo de casos desde 1991 a 2012. Resultados: Se identificaron 23 casos, dos de ellos de aparición nosocomial (8,7%). La edad promedio fue 68,4 años (rango 44-90). El 70% de los casos ha ocurrido desde el año 2003. Los factores predisponentes más frecuentes fueron edad > 65 años (60,9%), diabetes mellitus (40,9%) e inmunosupresión (27,3%). No se encontraron casos asociados a embarazo, infección por VIH o neonatos. La presentación clínica correspondió a infección del SNC (39%,) con ocho casos de meningitis y uno de romboencefalitis (5%); bacteriemias (43,5%) con un caso de endocarditis infecciosa; abscesos (8,7%) y un caso de neumonía y de peritonitis bacteriana espontánea (8,7%). El consumo de alimentos de riesgo fue buscado en cinco pacientes y confirmado en cuatro (80%). Las manifestaciones clínicas más frecuentes fueron fiebre (90,9%) y compromiso de conciencia (63,6%). La presencia de cefalea (OR 21 p < 0,05), o náuseas y/o vómitos (OR 50 p < 0,01) se asociaron en forma significativa a infección del SNC. Sólo 45,5% recibió una terapia antimicrobiana empírica inicial adecuada y 36,4% un esquema sinérgico. Ocho pacientes fallecieron (34,8%), desenlace que estuvo asociado a bacteriemia (OR 8,25; IC95 1,2-59 p < 0,05). Conclusiones: Las infecciones por L. monocytogenes parecen estar aumentando lentamente en Chile, producen infecciones en diferentes parénquimas, afectan a pacientes vulnerables, y tienen una alta letalidad, especialmente en el subgrupo con bacteriemia.


Assuntos
Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Listeria monocytogenes , Listeriose , Causas de Morte , Hospedeiro Imunocomprometido , Listeriose/complicações , Listeriose/tratamento farmacológico , Listeriose/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Estações do Ano
8.
Arch. med ; 9(2): 99-109, Dic. 2009. graf, tab
Artigo em Espanhol | LILACS | ID: lil-544968

RESUMO

Objetivo: Identificar la prevalencia, la edad al momento del diagnóstico, la prevalencia según el género, determinar los métodos diagnósticos más utilizados, el tratamiento recibido, y la evolución de los pacientes hospitalizados por cardiopatías congénitas en el Hospital Infantil Universitario “Rafael Henao Toro” de la ciudad de Manizales (Colombia).Materiales y métodos: Se realizó un estudio de corte transversal en el cual se analizaron, desde agosto de 2008 hasta febrero de 2009, 105 historias clínicas de pacientes diagnosticados con cardiopatías congénitas entre los años 2000 y 2008.Resultados: De 105 pacientes, 51.4 porciento eran de género femenino; 67.6% provenían de área urbana; la mayor prevalencia se dio en comunicación interauricular 48.6%; en el 99.0% de los casos se usó la ecocardiografia bidimensional como método diagnóstico paraclínico; el 28.6 por ciento usó la furosemida como tratamiento médico. La población presentó una sobrevida del 87.6 por ciento.Conclusiones: Este estudio mostró que las cardiopatías congénitas de mayor prevalecía fueron comunicación interauricular 48.6 por ciento y comunicación intraventricular (46.7 por ciento), y en el género femenino 51.4 por ciento...


Assuntos
Isquemia Miocárdica/congênito , Mortalidade , Prevalência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA